Producers of dynamic random access memory, or DRAM, which includes Micron Technology (NASDAQ:MU), Samsung (OTCPK:SSNLF) and ...

The former chief financial officer of Coral Gables-based International Finance Bank will now serve in the same role for Grove ...

Opinions expressed by Forbes Contributors are their own. John Navin is a Colorado-based journalist who writes about stocks.

Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.

This year, YO-Wash Care Association was selected as the Global Innovation Challenge grant to receive US$500,000 from Citi ...

The broker cut its price target by 10 per cent amid fears that higher US tariffs and underwhelming Chinese stimulus will ...

Citi's (NYSE:C) financial compliance framework is also a focus in the investigation, which has taken hold for more than a ...

Citi Indonesia reported a 32 percent increase in net income for the first nine months of 2024, reaching Rp 2.2 trillion ...

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ: AMGN), Biogen (NASDAQ: BIIB), Gilead (NASDAQ ...

Shares of Hims & Hers ($HIMS) plummeted nearly 15% on Thursday after Amazon.com, Inc. ($AMZN) launched its new Amazon One ...

Citi lowered the firm’s price target on Kuehne & Nagel to CHF 188 from CHF 205 and keeps a Sell rating on the shares. Published ...

Citigroup Inc. is being investigated by US government agencies over its ties to a sanctioned Russian official, according to a ...